Cardiol Therapeutics Net Debt Growth & History (CRDL)
Cardiol Therapeutics's net debt was −$21.3M for fiscal 2025.
View full Cardiol Therapeutics company overviewCardiol Therapeutics annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$21.3M | $9.1M | — |
| 2024 | 2024-12-31 | −$30.4M | $4.3M | — |
| 2023 | 2023-12-31 | −$34.8M | $24.6M | — |
| 2022 | 2022-12-31 | −$59.4M | $24.4M | — |
| 2021 | 2021-12-31 | −$83.8M | −$69.9M | — |
| 2020 | 2020-12-31 | −$13.9M | — | — |
Cardiol Therapeutics quarterly net debt
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$26.0M | −$7.9M | — |
| Q1 2026 | 2026-03-31 | −$27.6M | −$4.4M | — |
| Q4 2025 | 2025-12-31 | −$21.3M | $9.1M | — |
| Q3 2025 | 2025-09-30 | −$11.5M | — | — |
| Q2 2025 | 2025-06-30 | −$18.1M | — | — |
| Q1 2025 | 2025-03-31 | −$23.1M | — | — |
| Q4 2024 | 2024-12-31 | −$30.4M | $4.3M | — |
| Q4 2023 | 2023-12-31 | −$34.8M | $24.6M | — |
| Q4 2022 | 2022-12-31 | −$59.4M | $24.4M | — |
| Q4 2021 | 2021-12-31 | −$83.8M | — | — |
Cardiol Therapeutics net debt trends
Over the last five fiscal years, Cardiol Therapeutics's net debt decreased from −$13.9M to −$21.3M, a change of −$7.4M. The latest reported quarter, Q2 2026, shows −$26.0M.
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cardiol Therapeutics source filings ↗